Exhibit 107

 

CALCULATION OF FILING FEE TABLE

 

Form S-8

(Form Type)

 

Sonnet BioTherapeutics Holdings, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered Securities

 

Security Type   Security Class Title   Fee Calculation Rule   Amount
Registered(1)
    Proposed Maximum Offering Price Per Unit(2)     Proposed
Aggregate Offering
Price(2)
    Fee Rate     Amount of
Registration Fee(2)
 
Equity   Common stock, $0.0001 par value per share   Rule 457(c) and Rule 457(h)     318,561     $ 0.33     $ 105,125.13     $ 0.00011020     $ 11.58  
    Total Offering Amounts               $ 105,125.13               11.58  
    Total Fee Offsets                                 -  
    Net Fee Due                               $ 11.58  

 

(1) Covers 318,561 shares of common stock issuable under the Sonnet BioTherapeutics Holdings, Inc. 2020 Omnibus Equity Incentive Plan (the “2020 Plan”), and, pursuant to Rule 416(c) under the Securities Act of 1933, as amended (the “Securities Act”), an indeterminable number of shares of common stock issuable under the 2020 Plan, as these amounts may be adjusted as a result of stock splits, stock dividends, antidilution provisions, and similar transactions.
   
(2) Pursuant to Rule 457(c) and Rule 457(h) under the Securities Act, the proposed maximum offering price per share and the proposed maximum aggregate offering price are estimated for the purpose of calculating the amount of the registration fee and are based on the average of the high and low sales price on the Nasdaq Capital Market on August 15, 2023.